Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel endolysin disruptsStreptococcus suiswith high efficiency

3 Nov 2015

Abstract excerpt

Streptococcus suis serotype 2 (S. suis 2) is a zoonotic pathogen that exhibits high-level resistance and multi-drug resistance to classic antibiotics and causes serious human casualties and heavy economic losses in the swine industry worldwide. Therefore, alternative therapies or novel antibacterial agents need to be developed to combat this pathogen. A novel endolysin derived from the S. suis temperate phage...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Infections and bacterial resistance
Share to Neonatal and Maternal Infections
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26534896
DOI: 10.1093/femsle/fnv205

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel endolysin disruptsStreptococcus suiswith high efficiencyPMID 26534896Read ↗

Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to BedsideSemantic proximity Read ↗

Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogenSemantic proximity Read ↗

Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus ?Semantic proximity Read ↗

LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococciSemantic proximity Read ↗

Bacteriophage as a potential biotherapeutics to combat present-day crisis of multi-drug resistant pathogensSemantic proximity Read ↗

Phage-Encoded EndolysinsSemantic proximity Read ↗

The efficacy of bacteriophage-encoded endolysin relies on active residues: A molecular perspectiveSemantic proximity Read ↗

Morin Attenuates Streptococcus suis Pathogenicity in Mice by Neutralizing Suilysin ActivitySemantic proximity Read ↗

<i>Streptococcus</i> Phage Genomes Reveal Extensive Diversity, New Taxonomic Insights, and Novel Endolysin-Derived Antimicrobial PeptidesSemantic proximity Read ↗

Application of bacteriophage-derived endolysins to combat streptococcal disease: current state and perspectivesSemantic proximity Read ↗

Identification and characterisation a surface-associated arginine peptidase in Streptococcus suis serotype 2.Semantic proximity Read ↗

Antimicrobial bacteriophage-derived proteins and therapeutic applicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.